25228805|t|Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain.
25228805|a|An innovative drug delivery technology is urgently needed to satisfy unmet medical needs in treating various brain disorders. As a fundamental carrier for plasmid DNA or nucleic acids, we developed a liposomal nanoparticle (multifunctional envelope-type nano device [MEND]) containing a proton-ionizable amino lipid (YSK-MEND). Here we report on the impact of apolipoprotein E (ApoE) modification on the function of YSK-MEND in terms of targeting brain cells. The cellular uptake and function of YSK-MEND encapsulating short interference RNA or plasmid DNA were significantly improved as a result of ApoE modification in mouse neuron-derived cell lines (Neuro-2a and CAD). Intracerebroventricular administration of ApoE-modified YSK-MEND (ApoE/YSK-MEND) encapsulating plasmid DNA also resulted in higher transgene expression in comparison with YSK-MEND that was not modified with ApoE. Moreover, observation of fluorescence-labeled ApoE/YSK-MEND and expression of mCherry (fluorescence protein) derived from plasmid DNA indicated that this carrier might be useful for delivering and conferring transgene expression in neural stem cells and/or neural progenitor cells. Thus, this system may be a useful tool for the treatment of neurodegenerative disease. 
25228805	15	31	apolipoprotein E	Gene	11816
25228805	237	252	brain disorders	Disease	MESH:D001927
25228805	395	399	MEND	Disease	OMIM:300960
25228805	438	443	lipid	Chemical	MESH:D008055
25228805	445	453	YSK-MEND	CellLine	CVCL:6745
25228805	488	504	apolipoprotein E	Gene	11816
25228805	506	510	ApoE	Gene	11816
25228805	544	552	YSK-MEND	CellLine	CVCL:6745
25228805	624	632	YSK-MEND	CellLine	CVCL:6745
25228805	728	732	ApoE	Gene	11816
25228805	749	754	mouse	Species	10090
25228805	782	790	Neuro-2a	CellLine	CVCL:0470
25228805	795	798	CAD	CellLine	CVCL:0199
25228805	843	847	ApoE	Gene	11816
25228805	857	865	YSK-MEND	CellLine	CVCL:6745
25228805	867	871	ApoE	Gene	11816
25228805	872	880	YSK-MEND	CellLine	CVCL:6745
25228805	972	980	YSK-MEND	CellLine	CVCL:6745
25228805	1060	1064	ApoE	Gene	11816
25228805	1065	1073	YSK-MEND	CellLine	CVCL:6745
25228805	1356	1381	neurodegenerative disease	Disease	MESH:D019636
25228805	Association	MESH:D019636	11816

